RecruitingPhase 2NCT05102396

Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?

Topical Oxybutynin Deodorant for Axillary Hyperhidrosis: Local or Systemic Effect? The TODAY Trial

Sponsor

Samantha Rodrigues Camargo Neves de Moura

Enrollment

17 participants

Start Date

Sep 26, 2022

Study Type

INTERVENTIONAL

Conditions

The TODAY trial is a study to evaluate the efficacy and safety of topical oxybutynin deodorant for use in patients with axillary hyperhidrosis.

Min Age: 18 YearsMax Age: 45 Years

Patients aged ≥18 years and ≤ 45 years
Not treated patient with another drug or treatment methodology for the disease for at least 30 days

Patients who are hypersensitive to oxybutynin hydrochloride.
Not treated patient with another drug or treatment methodology for the disease for at least 30 days
Patients who have menopausal symptoms
Patients who show signs of skin lesions in the armpit
Pregnancy. Women with the potential to bear children should be under contraceptive strategies and take a negative pregnancy test to be enrolled
Patients with COVID in the contagious phase (PCR+)

Interested in this trial?

Get notified about updates and connect with the research team.